You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TARS Sale Disclosure
Azamian Bobak R. · SEC Form 4 · Filed Sep 3, 2026
Sale
Calculated transaction value
$800.6K
Azamian Bobak R. President/CEO And Board Chair
TARS
Transaction date
Sep 2, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed 1 day later
TARS daily price context
Close on/before transaction
$82.76
Sep 2, 2026
First close after public filing
$90.78
Sep 4, 2026
30-day return after filing
-17.98%
Through Oct 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 10,000 shares @ $80.06
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001827672-26-000011
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$800.6K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS Current | Sale | Sep 2, 2026 | $800.6K |